Relisys Medical Devices Limited

RelisysPristine+ : Everolimus Eluting Cobalt Chromium Coronary Stent System

SHARE
Highlighting Features: • Pristine+ elutes Everolimus drug which is the most preferred drug by most of the interventional cardiologists • The basic stent platform for Pristine+ is L605 Cobalt Chromium stent • The strut thickness for Pristine+ is 60 μm • Pristine+ displays minimum recoil and excellent radial strength contributed by its unique open and closed cell stent design and strut locking mechanism • Pristine+ comes with rapid exchange Delivery System which enhances its efficacy • Uniform Everolimus Coating thickness and precise in Everolimus Drug Release Kinetics as 95 +/- 5% of Everolimus is released within 120 days • Hydrophilic Coated Stent Delivery System • Designed for utmost safety – Pristine+ displays one of the lowest entry profiles • Completely biodegradable, biocompatible polymer (PLGA carrier) – Loading dose density of 1.0μg/mm²